A Dual-Antigen SARS-CoV-2 Serological Assay Reflects Antibody Avidity
暂无分享，去创建一个
Serial antibody measurements using an array of SARS-CoV-2 immunoassays have demonstrated differing kinetics among assay platforms (1).….
[1] Patrick W. Johnson,et al. SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods , 2021, Journal of clinical microbiology.
[2] K. Bates,et al. Marked Increase in Avidity of SARS-CoV-2 Antibodies 7–8 Months After Infection Is Not Diminished in Old Age , 2021, Journal of Infectious Diseases.
[3] G. Torriani,et al. Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2 , 2020, Journal of Clinical Microbiology.